Cerebrovascular Syndromes Following Cardiac Transplantation
Neurol 42:819-823, Adair,J.C.,et al, 1992
Clinicopathologic Conference, Vascular Ehlers-Danlos Syndrome
NEJM 385:1317-1325, Case 30-2021, 2021
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Heritable Connective Tissue Disorders in Cervical Artery Dissections:A Prospective Study
Neurol 50:1166-1169, Schievink,W.I.,et al, 1998
Intracranial Abnor in Infants Treated with Extracorporeal Membrane Oxygenation:Update on Sonographic & CT Findings
AJNR 17:287-294, Bulas,D.I.,et al, 1996
Cerebrovascular Complications in Ehlers-Danlos Syndrome Type IV
Ann Neurol 38:960-964, North,K.N.,et al, 1995
Neurovascular Manifestations of Heritable Connective Tissue Disorders:A Review
Stroke 25:889-903, Schievink,W.I.,et al, 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Neurologic Manifestations of Progressive Systemic Sclerosis
Arch Neurol 49:1292-1295, Averbuch-Heller,L.,et al, 1992
Clinical and Laboratory Findings in Patients with Antiphospholipid Antibodies and Cerebral Ischemia
Study Group, Stroke 21:1268-12731990., , 1990
Thrombolytic Therapy:Current Status (Second of Two Parts)
NEJM 318:1585-1595, Marder,V.J.&Sherry,S., 1988
Thrombolytic Therapy in Cerebrovascular Disease
Stroke 19:1174-1179, DelZoppo,G.J., 1988
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Causes of Recurrent Laryngeal Nerve Paralysis
Arch Otolaryngol 102:259-261, Titche,L.L., 1976